SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

SWTXSell

Springworks Therapeutics, Inc.

Saqib Islam · CEO

$2.0M−4.0%Sep 4
SWTXSell

Springworks Therapeutics, Inc.

Badreddin Edris · COO

$813K−8.0%Sep 4
SWTXSell

Springworks Therapeutics, Inc.

Saqib Islam · CEO

$2.0M−4.0%Jun 5
SWTXSell

Springworks Therapeutics, Inc.

Julie Hambleton · Director

$186K−53.0%Jun 5
SWTXSell

Springworks Therapeutics, Inc.

Badreddin Edris · COO

$801K−7.0%Jun 5
SWTXSell

Springworks Therapeutics, Inc.

Daniel Pichl · Chief People Officer

$752K−25.0%Feb 20
SWTXSell

Springworks Therapeutics, Inc.

Bhavesh Ashar · Chief Commercial Officer

$381K−12.0%Feb 5
SWTXSell

Springworks Therapeutics, Inc.

Daniel Pichl · Chief People Officer

$1.2M−37.0%Feb 5
SWTXSell

Springworks Therapeutics, Inc.

Julie Hambleton · Director

$71K−34.0%Jul 21
SWTXSell

Springworks Therapeutics, Inc.

Julie Hambleton · Director

$65K−25.0%Jun 22
SWTXSell

Springworks Therapeutics, Inc.

Jeffrey Lawrence Schwartz · Director

$49.9M−36.0%Mar 20
SWTXSell

Springworks Therapeutics, Inc.

Julie Hambleton · Director

$35K−19.0%Mar 16
SWTXSell

Springworks Therapeutics, Inc.

Daniel Pichl · Chief People Officer

$27K−2.0%Jan 27
SWTXSell

Springworks Therapeutics, Inc.

Orbimed Advisors LLC · 10% owner

$4.9M−3.0%Sep 14
SWTXSell

Springworks Therapeutics, Inc.

Orbimed Advisors LLC · 10% owner

$10.5M−5.0%Aug 10
SWTXSell

Springworks Therapeutics, Inc.

Saqib Islam · CEO

$592K−1.0%Oct 20
SWTXSell

Springworks Therapeutics, Inc.

Saqib Islam · CEO

$3.1M−6.0%Oct 19
SWTXSell

Springworks Therapeutics, Inc.

L. Mary Smith · Chief Development Officer

$560K−6.0%Oct 13
SWTXSell

Springworks Therapeutics, Inc.

Bain Capital Life Sciences Investors, LLC · 10% owner

$70.3M−17.0%Aug 12
SWTXSell

Springworks Therapeutics, Inc.

Saqib Islam · CEO

$4.8M−7.0%Jul 20
SWTXSell

Springworks Therapeutics, Inc.

L. Mary Smith · Chief Development Officer

$809K−6.0%Jul 14
SWTXSell

Springworks Therapeutics, Inc.

Orbimed Advisors LLC · 10% owner

$1.4MJul 6
SWTXSell

Springworks Therapeutics, Inc.

Badreddin Edris · COO

$2.7M−10.0%Jul 1
SWTXSell

Springworks Therapeutics, Inc.

Orbimed Advisors LLC · 10% owner

$554KJun 30
SWTXSell

Springworks Therapeutics, Inc.

Orbimed Advisors LLC · 10% owner

$4.8M−1.0%Jun 25
SWTXSell

Springworks Therapeutics, Inc.

Orbimed Advisors LLC · 10% owner

$2.6M−1.0%Jun 14
SWTXSell

Springworks Therapeutics, Inc.

Orbimed Advisors LLC · 10% owner

$4.1M−1.0%Jun 9
SWTXSell

Springworks Therapeutics, Inc.

Stephen P Squinto · Director and 10% owner

$1.5M−13.0%Apr 28
SWTXSell

Springworks Therapeutics, Inc.

Saqib Islam · CEO

$4.3M−7.0%Apr 20
SWTXSell

Springworks Therapeutics, Inc.

Stephen P Squinto · Director and 10% owner

$118K−1.0%Apr 19
SWTXSell

Springworks Therapeutics, Inc.

L. Mary Smith · Chief Development Officer

$681K−6.0%Apr 13
SWTXSell

Springworks Therapeutics, Inc.

Bain Capital Life Sciences Investors, LLC · 10% owner

$103.7M−20.0%Mar 11
SWTXSell

Springworks Therapeutics, Inc.

Orbimed Advisors LLC · 10% owner

$101.5M−16.0%Mar 3
SWTXSell

Springworks Therapeutics, Inc.

Badreddin Edris · COO

$2.7M−11.0%Jan 26
SWTXSell

Springworks Therapeutics, Inc.

L. Mary Smith · Chief Development Officer

$787K−6.0%Jan 21
SWTXSell

Springworks Therapeutics, Inc.

Saqib Islam · CEO

$4.9M−5.0%Jan 21

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.